Nykredit A/S’s Pfizer PFE Stock Holding History

Nykredit A/S’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$206M	Buy	+8,545,428	New	+$224M	0.65%	32

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Nykredit A/S's PFE Position: Q2 2026 in Review

Nykredit A/S opened a new position in Pfizer (PFE) in Q2 2026: 8,545,428 shares worth $206M. The stake represents 0.65% of the portfolio and ranks #32 among its holdings.

2,380 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Nykredit A/S held 8,545,428 shares of Pfizer worth $206M as of Q2 2026.
Pfizer was a new Nykredit A/S position in Q2 2026.
Pfizer made up 0.65% of Nykredit A/S's portfolio in Q2 2026, its #32 holding.
2,380 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.